14 drugs identified as most urgently needing study for off-label use, Stanford professor says

Physicians and policy-makers know that drugs are frequently prescribed to treat certain diseases despite a lack of FDA approval — a practice known as off-label prescribing. Yet they say the problem is so big they don't know how to begin tackling it.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news146751196.html">14 drugs identified as most urgently needing study for off-label use, Stanford professor says</a></p> <p>Physicians and policy-makers know that drugs are frequently prescribed to treat certain diseases despite a lack of FDA approval — a practice known as off-label prescribing. Yet they say the problem is so big they don't know how to begin tackling it.</p>